focus -WSS

focus

author：knowledge 2025-10-01 02:11:56 - browse：6369

empty test tubes in the hand. -- first opinion coverage from STAT — Adobe

The Food and Drug Administration on Friday announced its intention to start regulating tests developed in laboratories — closing the “Theranos loophole” that has allowed inaccurate tests to slip through the cracks.

Lawmakers came close last year to passing a bill that would have given the FDA this authority, but it was ultimately rejected by Republicans who sympathized with the labs in academic medical centers and hospitals that opposed the provision. FDA Commissioner Robert Califf said at the time that if the bill failed, the agency would take matters into its own hands.

The proposed rule fulfills that promise, adding lab diagnostics to the list of devices that fall under FDA enforcement — a move that patient groups and non-lab test makers support, and that laboratories are likely to dispute. When the FDA started regulating medical devices in 1976, lab-developed tests were simple and offered mostly to local patient populations. The agency generally allowed labs to use these tests without submitting proof of their efficacy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
Next article： Senators: Long

WSS

Readout LOUD podcast: possible new ALS drug, artificial wombs

What Congress can do to address the rural doctor shortage

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Listen: Racing for gene therapy & a pioneering approval

Biotech lab space demand falls sharply

New details revealed about Purdue's marketing of OxyContin

Wikipedia

focus

entertainment

Medical records are filled with copy

FDA panel to weigh approval of NurOwn, controversial ALS drug

Psychedelics group wrestles with new pharma identity

Living with Hashimoto's and celiac disease, and med school, too

In age of alternative facts, a scholarly course on calling out crap

Readout LOUD podcast: possible new ALS drug, artificial wombs

Alkermes shareholders re

Emergency workers more likely to restrain Black patients: study

How one medical school became remarkably diverse

Living with Hashimoto's and celiac disease, and med school, too

focus

Lung cancer is America's deadliest cancer. Yet so few get screened

The pain doctors face in trying to build their families

Hilary expected to bring catastrophic, life

CDC advisers recommend seasonal use of Pfizer RSV shot

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Hearing on Medicare drug price negotiation gets unusually heated

focus

hotspot

hotspot

entertainment